Moore Paul Andrew
- SEC CIK
- 0001938192
In the past year, 2 open-market sale filings worth $721.5K and no purchases.
Current role at each company
- ZYME Zymeworks Inc.Chief Scientific Officeras of Jan 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $721.5K
- 2 filings
- Net
- −$721.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Moore Paul Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 (view filing) | Jan 12 | Same day | Moore Paul AndrewChief Scientific Officer | SSale | −9.56K | $22.67 | −$216.7K | −16.5%48.5K after | |
| Jan 5, 2026 (view filing) | Jan 5 | Same day | Moore Paul AndrewChief Scientific Officer | SSale | −20.1K | $25.10 | −$504.8K | −33.2%40.4K after | 2 lots |
| Jan 6, 2025 (view filing) | Jan 6 | Same day | Moore Paul AndrewChief Scientific Officer | SSale | −21.2K | $14.92 | −$316.3K | −47.6%23.3K after | 2 lots |
| Jan 8, 2024 (view filing) | Jan 5-8 | 3 days | Moore Paul AndrewChief Scientific Officer | SSale | −9.80K | $10.79 | −$105.7K | −57.1%7.37K after | 2 lots |